Purchase Order 75N91019P00470

<p>The National Cancer Institute awarded a purchase order to Polypeptide Laboratories San Diego, LLC for $14,000 on July 6, 2020. Work will be performed in San Diego, California. The order procures stability testing of reagents used in vaccine manufacturing to support two active clinical trials, with firm fixed price terms and an ultimate completion date of August 5, 2020.</p>

The National Cancer Institute issued an $85,762 delivery order to Societal CDMO San Diego, LLC on January 7, 2019, for the manufacture of 1,600 hard gelatin capsules of TD-CYD at 10 mg strength under CGMP conditions for clinical use. Place of performance is San Diego, CA 92121. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of July 7, 2019. Societal CDMO San Diego, LLC is a self-certified small disadvantaged business and subsidiary of Irisys Inc., a...

The National Cancer Institute issued a $9,916 delivery order to Societal CDMO San Diego, LLC on November 20, 2019, for development and manufacture of oral and topical dosage forms under a cost-plus-fixed-fee pricing structure. Place of performance is San Diego, CA 92121. The order is due for ultimate completion on December 19, 2019. Societal CDMO San Diego, LLC is a self-certified small disadvantaged business and subsidiary of Irisys Inc., a contract development and manufacturing organization...

<p>The National Cancer Institute awarded a purchase order to Polypeptide Laboratories San Diego, LLC for $17,500 on December 4, 2020. The order covers mandatory retesting of GMP peptides used to manufacture clinical vaccines for prostate cancer patients, with performance in San Diego, California and completion by January 3, 2021. Pricing is firm fixed price.</p>

The National Cancer Institute issued a delivery order to Societal CDMO San Diego, LLC on July 30, 2015, with a ceiling value of $89,418.97 for special studies and analysis in chemical and biological manufacturing of oral and topical dosage forms. Societal CDMO San Diego, LLC is a self-certified small disadvantaged business. Place of performance is San Diego, CA 92121. The order has an ultimate completion date of June 29, 2020 and is priced on a cost-plus-fixed-fee basis. The awardee operates...

The National Cancer Institute issued a delivery order to Societal CDMO San Diego, LLC on October 25, 2018, with a ceiling value of $71,645.00 for production of 4 milligrams of AZA-TDC capsules for clinical use. Place of performance is San Diego, CA 92121. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of April 30, 2019. Societal CDMO San Diego, LLC is a self-certified small disadvantaged business and subsidiary of Irisys, Inc., a contract development and...

The National Cancer Institute issued a delivery order to Societal CDMO San Diego, LLC on January 7, 2019, with a ceiling value of $176,862.00 for manufacturing Indenos (LMP744, NSC 706744) for injection, 50 milliliter fill, under Good Manufacturing Practice conditions using the process employed for lot number 15LM092 in support of Phase I/II clinical trials. Place of performance is San Diego, CA 92121. The order is cost-plus-fixed-fee and concludes October 6, 2019. Societal CDMO San Diego, LLC...

The National Cancer Institute issued a delivery order to Societal CDMO San Diego, LLC on April 17, 2019, with a ceiling value of $97,042.00 for the production of two thousand capsules of 8 mg AZA-TDC. Place of performance is San Diego, CA. The period of performance runs from April 17, 2019 through April 16, 2020. The order is priced on a cost-plus-fixed-fee basis. No set-aside was used. Societal CDMO San Diego, LLC is a self-certified small disadvantaged business operating as a contract...

Societal Cdmo San Diego, LLC was awarded a $78,600 firm fixed price delivery order against the National Cancer Institute Cooperative Agreement for Cancer Target Discovery and Preclinical Validation Studies master indefinite-delivery/indefinite-quantity contract by the Department of Health and Human Services' National Institutes of Health. Under the delivery order, Societal Cdmo San Diego, LLC will provide metarestin storage and stability testing services for the National Cancer Institute,...

The National Cancer Institute issued a delivery order to Societal CDMO San Diego, LLC on May 10, 2019, with a ceiling value of $137,972.00 for the production of 1,000 vials of Triapine (NSC-663249) injection according to previous lot number 17TI038. Place of performance is San Diego, CA 92121. The order was priced on a cost-plus-fixed-fee basis with an ultimate completion date of May 9, 2020. Societal CDMO San Diego, LLC is a self-certified small disadvantaged business and subsidiary of...